Click on a filter below to refine your search. Remove a filter to broaden your search.
Poorer outcomes were seen for 30-day sustained clinical response and 14-day initial cure rates.
Despite patient beliefs, no effect was seen on the severity or duration of the cough.
41.5% of difficult-to-treat resistance episodes were treated exclusively with traditional agents.
Studies revealed that the medication reduced sleep apnea severity by nearly two-thirds.
Lower risks for first heart failure hospitalization and total heart failure hospitalization were seen with empagliflozin.
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Agency’s action could widen access to the drug if more insurance companies decide to cover it
The newly approved medication lowers the need for amputation of fingers or toes.
US prices for brand-name originator drugs are 422% higher, and the price of unbranded generics is 67% of comparison countries.